Carlyle to acquire Unchained Labs for $435mn

Exiting investors in the life sciences tools company are Novo Holdings A/S, Canaan Partners and TPG Biotech.

26 April 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles